Efficacy of a Telmisartan/S-Amlodipine on 24-hour BP Control in Hypertensive Patients Inadequately Controlled
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 208 participants.
Also called NCT02526875
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 208 participants
- Registry
-
NCT02526875
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT02526875. Randomized; no masking; primary purpose treatment. Start 2015-04 (registry gives no type); primary completion 2017-11 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy of a Telmisartan/S-Amlodipine on 24-hour BP Control in Hypertensive Patients Inadequately Controlled
- Condition
- Hypertension
- Intervention (Drug)
- Telminuvo®Tab. 40/2.5mg
- Lead sponsor
- Chong Kun Dang Pharmaceutical
Record details
- Record id
cardio:ct-nct02526875- Content hash
6a52382c2f95ebccce6dee24f68bc4b65a243daaace2750500b7f1e151a59a9d